作者: Joseph Zabner , Larry A. Couture , Richard J. Gregory , Scott M. Graham , Alan E. Smith
DOI: 10.1016/0092-8674(93)80063-K
关键词:
摘要: To evaluate the potential of direct transfer cystic fibrosis transmembrane conductance regulator (CFTR) cDNA for treatment (CF), we administered an E1-deficient adenovirus, encoding CFTR, to a defined area nasal airway epithelium three individuals with CF. This corrected Cl- transport defect that is characteristic CF-affected epithelia. After treatment, there was decrease in elevated basal transepithelial voltage, and normal response cAMP agonist restored. We found no evidence viral replication or virus-associated adverse effects, even at highest dose tested (25 MOI). These data represent small step achieving long-term improvement CF lung function by gene therapy.